- Report
- February 2023
- 266 Pages
Global
From €3184EUR$3,570USD£2,731GBP
€3746EUR$4,200USD£3,213GBP
- Report
- November 2024
- 120 Pages
Global
From €5307EUR$5,950USD£4,552GBP
- Report
- October 2023
- 75 Pages
Global
From €5307EUR$5,950USD£4,552GBP
- Report
- August 2025
- 184 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- August 2025
- 192 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- August 2025
- 192 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- August 2025
- 189 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- August 2025
- 189 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- April 2025
Global
From €4371EUR$4,900USD£3,749GBP
- Report
- August 2025
- 198 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- January 2024
- 200 Pages
Global
From €3702EUR$4,150USD£3,175GBP
- Report
- December 2023
- 109 Pages
Global
From €3568EUR$4,000USD£3,060GBP
- Report
- March 2024
- 118 Pages
Global
From €4014EUR$4,500USD£3,443GBP
- Report
- August 2025
- 188 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- December 2024
- 85 Pages
India
From €3122EUR$3,500USD£2,678GBP
- Report
- October 2023
- 78 Pages
United States
From €3122EUR$3,500USD£2,678GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1338EUR$1,500USD£1,148GBP
- Report
- June 2024
- 200 Pages
Global
From €7091EUR$7,950USD£6,082GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1784EUR$2,000USD£1,530GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1115EUR$1,250USD£956GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more